Peter Switzer of the Switzer Super Report asks “should one sell in May?”
Pitt Street Research initiates coverage of Anteo Diagnostics, Brisbane-based nanochemistry technology and diagnostics company.
Pitt Street Research has initiated coverage of Anatara Lifesciences with a bullish view on the recent licensing agreement with Zoetis.
Peter Switzer of the Switzer Super Report draws on central bank accommodation and trade optimism in suggesting it’s not time to sell.
Pitt Street Research sees a case for re-rating as Neuren keeps Rest-of-World rights for Trofinetide.
Peter Switzer of the Switzer Super Report has asked respected colleagues for their best tips in the current market.
Pitt Street Research has released an interview with ParaZero CEO Eden Attias.
Pitt Street Research has interviewed Credit Intelligence CEO Jimmie Wong
Peter Switzer of the Switzer Super Report argues why, when it comes to funds, past performance can indeed be an indicator of future performance.
Peter Switzer of the Switzer Super Report argues against the case for December stock market lows being retested.